Estimating COVID-19 prevalence and infection control practices among US dentists

Cameron G Estrich, Matthew Mikkelsen, Rachel Morrissey, Maria L Geisinger, Effie Ioannidou, Marko Vujicic, Marcelo W B Araujo, Cameron G Estrich, Matthew Mikkelsen, Rachel Morrissey, Maria L Geisinger, Effie Ioannidou, Marko Vujicic, Marcelo W B Araujo

Abstract

Background: Understanding the risks associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission during oral health care delivery and assessing mitigation strategies for dental offices are critical to improving patient safety and access to oral health care.

Methods: The authors invited licensed US dentists practicing primarily in private practice or public health to participate in a web-based survey in June 2020. Dentists from every US state (n = 2,195) answered questions about COVID-19-associated symptoms, SARS-CoV-2 infection, mental and physical health conditions, and infection control procedures used in their primary dental practices.

Results: Most of the dentists (82.2%) were asymptomatic for 1 month before administration of the survey; 16.6% reported being tested for SARS-CoV-2; and 3.7%, 2.7%, and 0% tested positive via respiratory, blood, and salivary samples, respectively. Among those not tested, 0.3% received a probable COVID-19 diagnosis from a physician. In all, 20 of the 2,195 respondents had been infected with SARS-CoV-2; weighted according to age and location to approximate all US dentists, 0.9% (95% confidence interval, 0.5 to 1.5) had confirmed or probable COVID-19. Dentists reported symptoms of depression (8.6%) and anxiety (19.5%). Enhanced infection control procedures were implemented in 99.7% of dentists' primary practices, most commonly disinfection, COVID-19 screening, social distancing, and wearing face masks. Most practicing dentists (72.8%) used personal protective equipment according to interim guidance from the Centers for Disease Control and Prevention.

Conclusions: COVID-19 prevalence and testing positivity rates were low among practicing US dentists. This indicates that the current infection control recommendations may be sufficient to prevent infection in dental settings.

Practical implications: Dentists have enhanced their infection control practices in response to COVID-19 and may benefit from greater availability of personal protective equipment. ClinicalTrials.gov: NCT04423770.

Keywords: COVID-19; SARS-CoV-2; dentistry.

Copyright © 2020 American Dental Association. Published by Elsevier Inc. All rights reserved.

Figures

Figure
Figure
Personal protective equipment (PPE) always worn in past month, according to dental procedure. OSHA: Occupational Safety and Health Administration. SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2.
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7560385/bin/fx1_lrg.jpg

References

    1. Centers for Disease Control and Prevention How COVID-19 spreads. Available at:
    1. Kissler S.M., Tedijanto C., Goldstein E., Grad Y.H., Lipsitch M. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science. 2020;368(6493):860–868.
    1. Prather K.A., Wang C.C., Schooley R.T. Reducing transmission of SARS-CoV-2. Science. 2020;368(6498):1422–1424.
    1. Wei W.E., Li Z., Chiew C.J., Yong S.E., Toh M.P., Lee V.J. Presymptomatic transmission of SARS-CoV-2: Singapore, January 23-March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):411–415.
    1. Kutter J.S., Spronken M.I., Fraaij P.L., Fouchier R.A., Herfst S. Transmission routes of respiratory viruses among humans. Curr Opin Virol. 2018;28:142–151.
    1. Harrel S.K., Molinari J. Aerosols and splatter in dentistry: a brief review of the literature and infection control implications. JADA. 2004;135(4):429–437.
    1. Meng L., Hua F., Bian Z. Coronavirus disease 2019 (COVID-19): emerging and future challenges for dental and oral medicine. J Dent Res. 2020;99(5):481–487.
    1. Centers for Disease and Prevention Guidance for Dental Settings: interim infection prevention and control guidance for dental settings during the coronavirus disease (COVID-19) pandemic. Available at:
    1. American Dental Association ADA interim guidance for minimizing risk of COVID-19 transmission. Available at: Accessed May 6, 2020.
    1. Centers for Disease Control and Prevention CDC COVID data tracker: maps, charts, and data provided by the CDC—United States COVID-19 cases and deaths by state. Available at:
    1. Health Policy Institute, American Dental Association COVID-19 economic impact: survey results. Available at:
    1. Centers for Disease and Prevention Coronavirus disease 2019 (COVID-19): cases, data, & surveillance—purpose and methods. Available at:
    1. Centers for Disease and Prevention Coronavirus disease 2019 (COVID-19): people at increased risk—and other people who need to take extra precautions, people at increased risk for severe illness. Available at:
    1. Löwe B., Wahl I., Rose M. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010;122(1-2):86–95.
    1. Pfizer Welcome to the Patient Health Questionnaire (PHQ) Screeners. Available at:
    1. US Department of Labor, Occupational Safety & Health Administration COVID-19: control and prevention—dentistry workers and employers. Available at:
    1. Czeisler M.É. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic: United States, June 24-30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1049–1057.
    1. Health Policy Institute, American Dental Association COVID-19: economic impact on dental practices—week of June 1 results. Available at:
    1. Centers for Disease Control and Prevention Interim guidelines for COVID-19 antibody testing: interim guidelines for COVID-19 antibody testing in clinical and public health settings. Available at:
    1. Kluytmans-van den Bergh M.F., Buiting A.G., Pas S.D. Prevalence and clinical presentation of health care workers with symptoms of coronavirus disease 2019 in 2 Dutch hospitals during an early phase of the pandemic. JAMA Network Open. 2020;3(5)
    1. Lai X., Wang M., Qin C. Coronavirus disease 2019 (COVID-2019) infection among health care workers and implications for prevention measures in a tertiary hospital in Wuhan, China. JAMA Network Open. 2020;3(5)
    1. Mani NS, Budak JZ, Lan KF, et al. Prevalence of COVID-19 infection and outcomes among symptomatic healthcare workers in Seattle, Washington [published online ahead of print June 16, 2020]. Clin Infect Dis.10.1093/cid/ciaa761.
    1. Centers for Disease and Prevention COVIDView summary ending on June 13, 2020. Available at:
    1. Johns Hopkins University & Medicine Coronavirus resource center: impact of opening and closing decisions by state—a look at how social distancing measures may have influenced trends in COVID-19 cases and deaths. Available at:
    1. Fang L., Karakiulakis G., Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):e21.
    1. Sheehan K.B. E-mail survey response rates: a review. J Comput Mediat Commun. 2001;6(2)
    1. Ketchum K., O'Connor L. COVID-19 testing problems started early, U.S. still playing from behind. Available at: Published May 11, 2020. Accessed July 6, 2020.
    1. Woloshin S., Patel N., Kesselheim A.S. False negative tests for SARS-CoV-2 infection: challenges and implications. N Engl J Med. 2020;383(6):e38.
    1. Burger D. ADA recommending dentists postpone elective procedures. ADA News. March 16, 2020. Available at: Accessed July 6, 2020.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren